Israel strikes Gaza during ceasefire, killing about 104 people, including many children and women, in retaliation for the killing of an Israeli soldier.
FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
Israel strikes Gaza during ceasefire, killing about 104 people, including many children and women, in retaliation for the killing of an Israeli soldier.
FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.